---
title: "Vaishali Pharma Ltd (VAISHALI) — Share Price, Financials & Analysis"
symbol: "VAISHALI"
company: "Vaishali Pharma Ltd"
canonical: "https://tapetide.com/stocks/VAISHALI"
isin: "INE972X01022"
nse_symbol: "VAISHALI"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
market_cap_cr: 110.11
generated_at: "2026-09-13T21:39:32.692Z"
---

# Vaishali Pharma Ltd (VAISHALI)

Canonical page: https://tapetide.com/stocks/VAISHALI

## Company

- **NSE Symbol:** VAISHALI
- **ISIN:** INE972X01022
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2020-01-15
- **Face Value:** ₹2
- **F&O Eligible:** No

## About

Incorporated in 1989, Vaishali Pharma Ltd 
does marketing of pharmaceutical products including active pharmaceutical ingredients[1]

## Latest Price

- **Price:** ₹8.77
- **Change:** +0.2 (+2.33%)
- **Open:** ₹8.22
- **Day High:** ₹9.42
- **Day Low:** ₹8.22
- **Previous Close:** ₹8.57
- **Volume:** 392962
- **As Of:** 2026-09-11T10:01:40+00:00

## Key Fundamentals

Observed at 2026-09-11T04:44:40.534673Z.

- **Market Cap:** ₹110.11 Cr
- **Classification:** Microcap
- **P/E (reported):** 25.2
- **P/E (TTM):** 25.79
- **EPS (TTM):** ₹0.34
- **Book Value:** ₹5.3
- **Price to Book:** 1.62
- **Dividend Yield:** 0%
- **ROE:** 1.26%
- **ROCE:** 4.02%
- **Debt to Equity:** 0.28
- **Revenue (yearly):** ₹108.77 Cr
- **Net Income:** ₹4.05 Cr
- **EBITDA:** ₹4.11 Cr
- **52-Week High:** ₹12.7
- **52-Week Low:** ₹4.75
- **RSI (14):** 61.2

## Tapetide Score

- **Score:** 44 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 25 (of 4473 scored stocks)
- **Confidence:** 89%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 46.37 | 9.89% |
| momentum | 78.9 | 13.19% |
| ownership | 44.15 | 26.37% |
| quality | 31.88 | 24.18% |
| valuation | 39.73 | 26.37% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Promoter holding has decreased over last quarter: -1.07%
- Promoter holding is low: 30.5%
- Earnings include an other income of Rs.3.57 Cr.
- Company has high debtors of 170 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | — | — | -997.51% |
| ebitda margin growth | 90.91% | 13.35% | 1.67% | -67.24% |
| net income growth | 300% | 406.25% | 478.57% | 1.25% |
| revenue growth | -16.67% | 6.43% | 7.2% | 6.99% |
| roce | — | -29.23% | -82.66% | 15.08% |
| roe | — | -25% | 6.41% | -73.02% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- |
| Sales | 33.45 | 24.65 | 26.93 | 22.89 |
| Expenses | 32.06 | 23.09 | 27.13 | 21.4 |
| Operating Profit | 1.39 | 1.56 | -0.2 | 1.49 |
| OPM % | 4.16 | 6.33 | -0.74 | 6.51 |
| Other Income | 0.84 | 0.89 | 1.26 | 0.58 |
| Interest | 0.4 | 0.51 | 0.72 | 0.2 |
| Depreciation | 0.17 | 0.13 | 0.16 | 0.14 |
| Profit before tax | 1.66 | 1.81 | 0.18 | 1.73 |
| Tax % | 28.31 | 28.18 | -61.11 | 13.87 |
| Net Profit | 1.19 | 1.32 | 0.41 | 1.55 |
| EPS in Rs | 0.09 | 0.1 | 0.03 | 0.12 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2026 | TTM |
| --- | --- | --- |
| Sales | 109 | 108 |
| Expenses | 105 | 104 |
| Operating Profit | 4 | 4 |
| OPM % | 3.8 | 3.9 |
| Other Income | 4 | 4 |
| Interest | 2 | 2 |
| Depreciation | 1 | 1 |
| Profit before tax | 5 | 5 |
| Tax % | 25 | — |
| Net Profit | 4 | 4 |
| EPS in Rs | 0.32 | 0.34 |
| Dividend Payout % | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2026 |
| --- | --- |
| Equity Capital | 26 |
| Reserves | 43 |
| Borrowings | 19 |
| Other Liabilities | 35 |
| Total Liabilities | 123 |
| Fixed Assets | 2 |
| CWIP | 0 |
| Investments | 6 |
| Other Assets | 116 |
| Total Assets | 123 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 5 | 0 | -9 | 4 | 3 | 2 | 1 | 1 | 1 | -18 |
| Cash from Investing Activity | 3 | 1 | 1 | 0 | 0 | 0 | -1 | 0 | 1 | 0 |
| Cash from Financing Activity | -8 | -1 | 8 | -4 | -3 | -2 | 0 | -2 | -1 | 18 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 |
| Free Cash Flow | 5 | 0 | -10 | 4 | 3 | 2 | 0 | 1 | 1 | -18 |
| CFO/OP | 842 | 16 | -326 | 212 | 433 | 78 | 31 | 28 | 185 | -3104 |

### Ratios

| Item | Mar 2026 |
| --- | --- |
| Debtor Days | 170 |
| Inventory Days | 13 |
| Days Payable | 81 |
| Cash Conversion Cycle | 102 |
| Working Capital Days | 212 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 26.62% | 26.62% | 26.32% | 26.32% | 26.32% | 26.32% | 26.32% | 26.32% | 26.32% | 31.61% | 31.61% | 31.61% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 62% | 60.94% | 62.93% | 66.11% | 64.98% | 64.93% | 65.24% | 65.88% | 67.25% | 62.75% | 62.32% | 62.79% |
| Others | 11.38% | 12.45% | 10.74% | 7.57% | 8.7% | 8.75% | 8.44% | 7.8% | 6.43% | 5.65% | 6.07% | 5.6% |
| No. of Shareholders | 9983 | 9181 | 9390 | 9479 | 18983 | 27546 | 28874 | 28682 | 27752 | 27752 | 26534 | 26671 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 6 / 1

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 8.3 | Buy |
| EMA (10) | 8.38 | Buy |
| SMA (20) | 8.24 | Buy |
| EMA (20) | 8.26 | Buy |
| SMA (50) | 7.97 | Buy |
| EMA (50) | 8 | Buy |
| SMA (100) | 7.66 | Buy |
| EMA (100) | 7.84 | Buy |
| SMA (200) | 7.69 | Buy |
| EMA (200) | 8.32 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 64.93 | Neutral |
| MACD (12,26,9) | 0.15 | Buy |
| Stochastic (14,3,3) | 65.09 | Neutral |
| ADX (14) | 11.28 | Neutral |
| Williams %R (14) | -40.12 | Neutral |
| ATR (14) | 0.5 | High Volatility |
| ROC (12) | 7.34 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 49.76 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-04 | [General Updates](https://nsearchives.nseindia.com/corporate/VAISHALI_04092026155410_Reg_30_Final.pdf) |
| 2026-09-03 | [Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/VAISHALI_03092026184207_News_paper_advertisment_FINAL.pdf) |
| 2026-09-01 | [General Updates](https://nsearchives.nseindia.com/corporate/VAISHALI_01092026203733_Book_Closure_Disclosure.pdf) |
| 2026-09-01 | [Record Date](https://nsearchives.nseindia.com/corporate/VAISHALI_01092026203214_Book_Closure_Disclosure.pdf) |
| 2026-09-01 | [Shareholders meeting](https://nsearchives.nseindia.com/corporate/VAISHALI_01092026202521_Notice_merged.pdf) |
| 2026-08-17 | [Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/VAISHALI_17082026180205_Cover_Letter_Final_Signed.pdf) |
| 2026-08-14 | [Resignation of Director/KMP/SMP](https://nsearchives.nseindia.com/corporate/VAISHALI_ROID_96568_KMP_Doc.zip) |
| 2026-08-14 | [Resignation](https://nsearchives.nseindia.com/corporate/VAISHALI_14082026200638_Reg_30_Resignation_Final.pdf) |
| 2026-08-14 | [Resignation of Director/KMP/SMP](https://nsearchives.nseindia.com/corporate/VAISHALI_ROID_96571_KMP_Doc.zip) |
| 2026-08-14 | [Resignation of Director/KMP/SMP](https://nsearchives.nseindia.com/corporate/VAISHALI_ROID_96567_KMP_Doc.zip) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/VAISHALI_14082026155157_Financials_VPL.pdf) |
| 2026-07-09 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/VAISHALI_09072026103331_BM_Outcome_VPL_Signed.pdf) |
| 2026-07-02 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/VAISHALI_02072026203023_BM_Outcome_New.pdf) |
| 2026-05-30 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/VAISHALI_30052026230014_BM_Outcome_VPL_final__1_.pdf) |
| 2026-05-23 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/VAISHALI_23052026154529_Outcome.pdf) |
| 2026-02-13 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/VAISHALI_13022026190039_Outcome_VPL_Signed.pdf) |
| 2026-02-13 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/VAISHALI_13022026193440_Outcome_VPL_Signed.pdf) |
| 2026-02-13 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/VAISHALI_13022026185536_Outcome_VPL_Signed.pdf) |
| 2025-11-14 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/VAISHALI_14112025194233_Sign_Outcome_final__2_.pdf) |
| 2025-11-14 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/VAISHALI_14112025194717_SignResults.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 24 June 2026 - Exchange has sought clarification from Vaishali Pharma Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (LODR) Regulations, 2015. On … | [Clarification - Financial Results 24 June 2026 - Exchange has sought clarification from Vaishali Pharma Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (LODR) Regulations, 2015. On …](https://www.nseindia.com/get-quotes/equity?symbol=VAISHALI) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/AR_31046_VAISHALI_2025_2026_A_10186020_01092026203054.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/AR_27921_VAISHALI_2024_2025_A_8838611_29082025203354.pdf) |
| from nse | [Annual Report 2024 from nse](https://archives.nseindia.com/annual_reports/AR_25614_VAISHALI_2023_2024_0309202420324.pdf) |
| from nse | [Annual Report 2023 from nse](https://archives.nseindia.com/annual_reports/AR_23768_VAISHALI_2022_2023_07092023173316_09072023180035.zip) |
| from nse | [Annual Report 2022 from nse](https://archives.nseindia.com/annual_reports/AR_21743_VAISHALI_2021_2022_08092022201059_09082022210006.zip) |
| from nse | [Annual Report 2021 from nse](https://archives.nseindia.com/annual_reports/AR_19680_VAISHALI_2020_2021_07092021225003_09072021230003.zip) |
| from nse | [Annual Report 2020 from nse](https://archives.nseindia.com/annual_reports/AR_17477_VAISHALI_2019_2020_07092020021518_07092020070002.zip) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2023 | [Concall - Nov 2023](https://nsearchives.nseindia.com/corporate/VAISHALI_29112023172034_Investor_Meet_Result.pdf) |
| May 2020 | [Concall - May 2020](https://archives.nseindia.com/corporate/VAISHALI_28052020090759_Vaishali_Pharma_Limited_Investor_Presentation_May_2020.pdf) |
| Feb 2024 | [Concall - Feb 2024](https://nsearchives.nseindia.com/corporate/VAISHALI_09022024183502_Investor_Meet_Transcript.pdf) |
| Aug 2020 | [Concall - Aug 2020](https://archives.nseindia.com/corporate/VAISHALI_06082020145314_Investor_Presentation_August_2020.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T21:39:32.692Z.